Pharmaceuticals

Biotech ETFs Still Promising Despite Hydroxychloroquine Trial

In the continuing quest to find a vaccine for the coronavirus, the World Health Organization announced Wednesday it is dropping hydroxychloroquine, the malaria drug backed by President Trump, who claims it has helped him, from its global study that examines potential treatments for Covid-19.

The WHO decided to terminate the trial following another separate trial that showed the drug would not be beneficial, said Ana Maria Henao Restrepo, a WHO medical officer.

Read more…